Filing Details
- Accession Number:
- 0001209191-19-035141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-06 17:08:54
- Reporting Period:
- 2019-06-04
- Accepted Time:
- 2019-06-06 17:08:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | Pharmaceutical Preparations (2834) | 510619477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1751757 | Roy Winston | C/O Pacira Biosciences, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054 | Chief Clinical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-06-04 | 722 | $42.91 | 16,539 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-06-05 | 5,600 | $0.00 | 22,139 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-06-05 | 33,800 | $0.00 | 33,800 | $43.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,800 | 2029-06-05 | No | 4 | A | Direct |
Footnotes
- Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- Includes 761 shares of common stock acquired under the issuer's employee stock purchase plan in December 2018.
- Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Billionaire Hedge Funds
